Common Prostate Cancer Medications May be Less Safe Than Previously Thought

May 20, 2022

 • 

Read time:

5-15 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Pills Background
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

Michigan Health Lab releases an article to talk about men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy. Michigan Medicine researchers found patients taking abiraterone had 1.77 times the risk of being admitted to the emergency room or the hospital due to diabetes, hypertension or heart disease compared to those who were only on hormone therapy. Lillian Y. Lai, M.D., M.S., a National Institutes of Health T32 Urologic Oncology Research Fellow at Michigan Medicine and the first author of the study, finds that all of these drugs might be harmful to your body and to watch what you have to take. 

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.